C
The startup develops therapeutic cell technologies for regenerative medicine, specifically targeting musculoskeletal-related diseases through its proprietary cell therapy platform. This approach addresses the unmet medical need for effective treatments in patients suffering from tissue injuries in the musculoskeletal system.
성남시, 대한민국
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops therapeutic cell technologies for regenerative medicine, specifically targeting musculoskeletal-related diseases through its proprietary cell therapy platform. This approach addresses the unmet medical need for effective treatments in patients suffering from tissue injuries in the musculoskeletal system.